Medacta Group SA
SIX:MOVE

Watchlist Manager
Medacta Group SA Logo
Medacta Group SA
SIX:MOVE
Watchlist
Price: 133.2 CHF 0.76%
Market Cap: 2.7B CHF

Wall Street
Price Targets

MOVE Price Targets Summary
Medacta Group SA

Wall Street analysts forecast MOVE stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MOVE is 155.45 CHF with a low forecast of 143.42 CHF and a high forecast of 168 CHF.

Lowest
Price Target
143.42 CHF
8% Upside
Average
Price Target
155.45 CHF
17% Upside
Highest
Price Target
168 CHF
26% Upside
Medacta Group SA Competitors:
Price Targets
AORT
Artivion Inc
41% Upside
IRTC
iRhythm Technologies Inc
22% Upside
GMED
Globus Medical Inc
40% Upside
ITGR
Integer Holdings Corp
20% Upside
ELMD
Electromed Inc
64% Upside
605186
Shanghai General Healthy Information and Technology Co Ltd
30% Upside
688677
Qingdao NovelBeam Technology Co Ltd
85% Upside
SRDX
Surmodics Inc
57% Upside

Revenue
Forecast

Revenue Estimate
Medacta Group SA

For the last 7 years the compound annual growth rate for Medacta Group SA's revenue is 13%. The projected CAGR for the next 3 years is 14%.

13%
Past Growth
14%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Medacta Group SA

For the last 7 years the compound annual growth rate for Medacta Group SA's operating income is 10%. The projected CAGR for the next 3 years is 15%.

10%
Past Growth
15%
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Net Income
Forecast

Net Income Estimate
Medacta Group SA

For the last 7 years the compound annual growth rate for Medacta Group SA's net income is 12%. The projected CAGR for the next 3 years is 17%.

12%
Past Growth
17%
Estimated Growth
Estimates Accuracy
-19%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MOVE's stock price target?
Price Target
155.45 CHF

According to Wall Street analysts, the average 1-year price target for MOVE is 155.45 CHF with a low forecast of 143.42 CHF and a high forecast of 168 CHF.

What is Medacta Group SA's Revenue forecast?
Projected CAGR
14%

For the last 7 years the compound annual growth rate for Medacta Group SA's revenue is 13%. The projected CAGR for the next 3 years is 14%.

What is Medacta Group SA's Operating Income forecast?
Projected CAGR
15%

For the last 7 years the compound annual growth rate for Medacta Group SA's operating income is 10%. The projected CAGR for the next 3 years is 15%.

What is Medacta Group SA's Net Income forecast?
Projected CAGR
17%

For the last 7 years the compound annual growth rate for Medacta Group SA's net income is 12%. The projected CAGR for the next 3 years is 17%.

Back to Top